Clinical Trial Update: MIS-C Comparative Effectiveness Study [Phase 2, Phase 3]

View source ↗

Summary

A comparative effectiveness study evaluating Multisystem Inflammatory Syndrome in Children (MIS-C) completed Phase 2 and Phase 3, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multisystem Inflammatory Syndrome in Children

Snippet

Sponsor: University of California, San Diego | Conditions: Multisystem Inflammatory Syndrome-Children | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-11-04